Simple and Practical Mental Health

The BEST resource for mental health clinicians

  • *MENUS*
  • RESOURCES
    • Side effect handouts
    • Patient Handouts: Main page
    • How to find specific types of treatments
    • Rating scales and questionnaires (Main Menu)
    • BEST books
    • BEST apps/ websites
  • NEWS
  • QUESTIONS?
  • DAILY EMAILS
  • FAQ
  • REVIEWS
  • LOG IN
  • JOIN

Aripiprazole and brexpiprazole: Impulsive or compulsive urges and behavior

On February 9, 2018, the FDA added the warning and instructions below to the approved drug label for brexpiprazole (brand name Rexulti). The Prescribing Information for aripiprazole (brand name Abilify) has carried the exact same warning since 2016. The third dopamine partial agonist, cariprazine (brand name Vraylar) does not carry this warning as of February…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Follow us on social media for important tips and updates

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Copyright 2016 to 2026: Simple and Practical Medical Education, LLC. All rights reserved.